AAPL335.92-1.10 (-0.33%) ▼|ABBV265.12+0.04 (+0.02%) ▲|ABT101.07-2.42 (-2.34%) ▼|ACN177.41-6.11 (-3.33%) ▼|ADBE238.93-1.76 (-0.73%) ▼|AMAT474.25-0.13 (-0.03%) ▼|AMD629.26+14.65 (+2.38%) ▲|AMGN406.04-0.05 (-0.01%) ▼|AMT167.26-3.52 (-2.06%) ▼|AMZN249.38+0.11 (+0.04%) ▲|AVGO350.36-4.63 (-1.30%) ▼|AXP305.66+3.70 (+1.23%) ▲|BA196.80-3.13 (-1.57%) ▼|BAC56.03+0.03 (+0.05%) ▲|BKNG157.41+1.51 (+0.97%) ▲|BLK1,073.45+12.56 (+1.18%) ▲|BMY61.50+0.35 (+0.57%) ▲|BNY150.19+0.68 (+0.45%) ▲|BRK-B505.18-1.99 (-0.39%) ▼|C132.10+0.17 (+0.13%) ▲|CAT805.25-6.77 (-0.83%) ▼|CL85.32-0.61 (-0.71%) ▼|CMCSA22.13-0.42 (-1.86%) ▼|COF196.61+0.51 (+0.26%) ▲|COP129.34+1.25 (+0.98%) ▲|COST896.48-8.22 (-0.91%) ▼|CRM238.22+0.64 (+0.27%) ▲|CSCO106.97+0.54 (+0.51%) ▲|CVS85.05-0.81 (-0.94%) ▼|CVX205.65+0.14 (+0.07%) ▲|DE694.94-14.54 (-2.05%) ▼|DHR223.77+2.21 (+1.00%) ▲|DIS105.56+2.10 (+2.03%) ▲|DUK113.23-0.94 (-0.82%) ▼|EMR156.14+1.55 (+1.00%) ▲|FDX279.54-11.96 (-4.10%) ▼|GD336.29-7.04 (-2.05%) ▼|GE319.78-0.02 (-0.01%) ▼|GEV955.04+3.22 (+0.34%) ▲|GILD149.69-1.68 (-1.11%) ▼|GM80.57-3.20 (-3.82%) ▼|GOOG339.01+4.03 (+1.20%) ▲|GOOGL342.36+4.53 (+1.34%) ▲|GS923.29-13.07 (-1.40%) ▼|HD292.18-4.54 (-1.53%) ▼|HON211.79-0.78 (-0.37%) ▼|IBM227.06-5.70 (-2.45%) ▼|INTC127.39+4.79 (+3.91%) ▲|INTU277.13-9.67 (-3.37%) ▼|ISRG399.52+1.22 (+0.31%) ▲|JNJ270.68+1.51 (+0.56%) ▲|JPM338.56+1.03 (+0.31%) ▲|KO88.10+0.01 (+0.01%) ▲|LIN468.14-1.58 (-0.34%) ▼|LLY1,181.89+30.90 (+2.68%) ▲|LMT523.70-0.98 (-0.19%) ▼|LOW188.49-2.87 (-1.50%) ▼|LRCX307.16-0.12 (-0.04%) ▼|MA566.08+6.16 (+1.10%) ▲|MCD237.02-1.30 (-0.55%) ▼|MDLZ60.86-0.58 (-0.94%) ▼|MDT88.51-0.79 (-0.88%) ▼|META777.59+33.49 (+4.50%) ▲|MMM167.52-2.78 (-1.63%) ▼|MO68.88-0.07 (-0.10%) ▼|MRK147.98-0.10 (-0.07%) ▼|MS196.32-2.07 (-1.04%) ▼|MSFT497.93-2.66 (-0.53%) ▼|MU1,080.53+8.65 (+0.81%) ▲|NEE75.62-1.40 (-1.82%) ▼|NFLX71.72+0.36 (+0.50%) ▲|NKE35.99-0.06 (-0.17%) ▼|NOW137.78-3.00 (-2.13%) ▼|NVDA224.58-0.93 (-0.41%) ▼|ORCL139.54-5.02 (-3.47%) ▼|PEP128.15-2.03 (-1.56%) ▼|PFE28.41+0.23 (+0.82%) ▲|PG145.68-1.71 (-1.16%) ▼|PLTR192.59+0.80 (+0.42%) ▲|PM191.50+0.66 (+0.35%) ▲|QCOM194.26-2.98 (-1.51%) ▼|RTX188.61-3.58 (-1.86%) ▼|SBUX93.65-0.49 (-0.52%) ▼|SCHW99.49-0.01 (-0.01%) ▼|SO82.89-0.58 (-0.69%) ▼|SPG204.70+0.54 (+0.26%) ▲|T25.45+0.15 (+0.59%) ▲|TMO678.39+13.09 (+1.97%) ▲|TMUS165.35-0.31 (-0.19%) ▼|TSLA377.94-2.18 (-0.57%) ▼|TXN270.65-1.97 (-0.72%) ▼|UBER69.22-0.20 (-0.29%) ▼|UNH375.01+3.72 (+1.00%) ▲|UNP274.07-1.46 (-0.53%) ▼|UPS92.05-3.77 (-3.93%) ▼|USB58.40-0.08 (-0.14%) ▼|V367.98+6.46 (+1.79%) ▲|VZ47.32+0.80 (+1.72%) ▲|WFC82.18+0.28 (+0.34%) ▲|WMT107.59-2.94 (-2.66%) ▼|XOM162.14+0.91 (+0.56%) ▲|AAPL335.92-1.10 (-0.33%) ▼|ABBV265.12+0.04 (+0.02%) ▲|ABT101.07-2.42 (-2.34%) ▼|ACN177.41-6.11 (-3.33%) ▼|ADBE238.93-1.76 (-0.73%) ▼|AMAT474.25-0.13 (-0.03%) ▼|AMD629.26+14.65 (+2.38%) ▲|AMGN406.04-0.05 (-0.01%) ▼|AMT167.26-3.52 (-2.06%) ▼|AMZN249.38+0.11 (+0.04%) ▲|AVGO350.36-4.63 (-1.30%) ▼|AXP305.66+3.70 (+1.23%) ▲|BA196.80-3.13 (-1.57%) ▼|BAC56.03+0.03 (+0.05%) ▲|BKNG157.41+1.51 (+0.97%) ▲|BLK1,073.45+12.56 (+1.18%) ▲|BMY61.50+0.35 (+0.57%) ▲|BNY150.19+0.68 (+0.45%) ▲|BRK-B505.18-1.99 (-0.39%) ▼|C132.10+0.17 (+0.13%) ▲|CAT805.25-6.77 (-0.83%) ▼|CL85.32-0.61 (-0.71%) ▼|CMCSA22.13-0.42 (-1.86%) ▼|COF196.61+0.51 (+0.26%) ▲|COP129.34+1.25 (+0.98%) ▲|COST896.48-8.22 (-0.91%) ▼|CRM238.22+0.64 (+0.27%) ▲|CSCO106.97+0.54 (+0.51%) ▲|CVS85.05-0.81 (-0.94%) ▼|CVX205.65+0.14 (+0.07%) ▲|DE694.94-14.54 (-2.05%) ▼|DHR223.77+2.21 (+1.00%) ▲|DIS105.56+2.10 (+2.03%) ▲|DUK113.23-0.94 (-0.82%) ▼|EMR156.14+1.55 (+1.00%) ▲|FDX279.54-11.96 (-4.10%) ▼|GD336.29-7.04 (-2.05%) ▼|GE319.78-0.02 (-0.01%) ▼|GEV955.04+3.22 (+0.34%) ▲|GILD149.69-1.68 (-1.11%) ▼|GM80.57-3.20 (-3.82%) ▼|GOOG339.01+4.03 (+1.20%) ▲|GOOGL342.36+4.53 (+1.34%) ▲|GS923.29-13.07 (-1.40%) ▼|HD292.18-4.54 (-1.53%) ▼|HON211.79-0.78 (-0.37%) ▼|IBM227.06-5.70 (-2.45%) ▼|INTC127.39+4.79 (+3.91%) ▲|INTU277.13-9.67 (-3.37%) ▼|ISRG399.52+1.22 (+0.31%) ▲|JNJ270.68+1.51 (+0.56%) ▲|JPM338.56+1.03 (+0.31%) ▲|KO88.10+0.01 (+0.01%) ▲|LIN468.14-1.58 (-0.34%) ▼|LLY1,181.89+30.90 (+2.68%) ▲|LMT523.70-0.98 (-0.19%) ▼|LOW188.49-2.87 (-1.50%) ▼|LRCX307.16-0.12 (-0.04%) ▼|MA566.08+6.16 (+1.10%) ▲|MCD237.02-1.30 (-0.55%) ▼|MDLZ60.86-0.58 (-0.94%) ▼|MDT88.51-0.79 (-0.88%) ▼|META777.59+33.49 (+4.50%) ▲|MMM167.52-2.78 (-1.63%) ▼|MO68.88-0.07 (-0.10%) ▼|MRK147.98-0.10 (-0.07%) ▼|MS196.32-2.07 (-1.04%) ▼|MSFT497.93-2.66 (-0.53%) ▼|MU1,080.53+8.65 (+0.81%) ▲|NEE75.62-1.40 (-1.82%) ▼|NFLX71.72+0.36 (+0.50%) ▲|NKE35.99-0.06 (-0.17%) ▼|NOW137.78-3.00 (-2.13%) ▼|NVDA224.58-0.93 (-0.41%) ▼|ORCL139.54-5.02 (-3.47%) ▼|PEP128.15-2.03 (-1.56%) ▼|PFE28.41+0.23 (+0.82%) ▲|PG145.68-1.71 (-1.16%) ▼|PLTR192.59+0.80 (+0.42%) ▲|PM191.50+0.66 (+0.35%) ▲|QCOM194.26-2.98 (-1.51%) ▼|RTX188.61-3.58 (-1.86%) ▼|SBUX93.65-0.49 (-0.52%) ▼|SCHW99.49-0.01 (-0.01%) ▼|SO82.89-0.58 (-0.69%) ▼|SPG204.70+0.54 (+0.26%) ▲|T25.45+0.15 (+0.59%) ▲|TMO678.39+13.09 (+1.97%) ▲|TMUS165.35-0.31 (-0.19%) ▼|TSLA377.94-2.18 (-0.57%) ▼|TXN270.65-1.97 (-0.72%) ▼|UBER69.22-0.20 (-0.29%) ▼|UNH375.01+3.72 (+1.00%) ▲|UNP274.07-1.46 (-0.53%) ▼|UPS92.05-3.77 (-3.93%) ▼|USB58.40-0.08 (-0.14%) ▼|V367.98+6.46 (+1.79%) ▲|VZ47.32+0.80 (+1.72%) ▲|WFC82.18+0.28 (+0.34%) ▲|WMT107.59-2.94 (-2.66%) ▼|XOM162.14+0.91 (+0.56%) ▲|
17.8 C
New York
Friday, September 25, 2026

Tag: information

newssourceFORcompanyinformationcontent1releasesmarket

PuroClean Sets Sights on Massachusetts for Strategic Franchise Expansion

Fifteen Territories Available Across Boston, the Coast, and Key Metro Areas; In-Market PROPEL Event Scheduled for July 30-31 TAMARAC, Fla., July 30, 2025 /PRNewswire/ --...

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Christian Dior: notice of availability of the half-yearly financial report as of June 30, 2025

NOTICE OF AVAILABILITY OF THE
HALF-YEARLY FINANCIAL REPORT AS OF JUNE 30, 2025

EuMentis Therapeutics Receives U.S. FDA Clearance of IND Application for EM-221, a Novel PDE10A Inhibitor for Schizophrenia

-Company expects to initiate Phase 2 study in 2H 2025- SAN DIEGO, July 30, 2025 /PRNewswire/ -- EuMentis Therapeutics, Inc., ("EuMentis"), a clinical-stage drug development company...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

OpenText to Showcase AI-Driven Threat Detection, Identity Security, and Application Protection at Black Hat USA 2025

WATERLOO, ON, July 30, 2025 /CNW/ -- OpenText™ (NASDAQ:OTEX), (TSX:OTEX) will join global cybersecurity leaders at Black Hat USA 2025 to showcase how organizations...

Fast Casual Concepts, Inc. Announces Strategic Business Move into the Marketing Industry

Fast Casual Concepts, Inc. Announces Strategic Business Move into the Marketing Industry

OpenText to Showcase AI-Driven Threat Detection, Identity Security, and Application Protection at Black Hat USA 2025

WATERLOO, ON, July 30, 2025 /PRNewswire/ -- OpenText™ (NASDAQ:OTEX), (TSX:OTEX) will join global cybersecurity leaders at Black Hat USA 2025 to showcase how organizations...

Form 8.3 – Primary Health Properties Plc

8.3

Vystar Introduces New RxAir-800 Replacement Cartridge Extended Life UV-C Bulb

New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use.

Mohawk Industries reporta resultados del segundo trimestre 2025

CALHOUN, Georgia, July 30, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) anunció hoy utilidades netas del segundo trimestre de 2025 por $ 147 millones y utilidades por acción ('EPS') de $ 2.34; las utilidades netas ajustadas fueron de $ 173 millones, y la EPS ajustada fue de $ 2.77. Las ventas netas del segundo trimestre de 2025 fueron de $2.8 mil millones, esencialmente sin cambios, según lo reportado y una disminución de 0.8% ajustada en base a los días constantes y tipos de cambio, en comparación con el año anterior. Durante el segundo trimestre de 2024, la empresa reportó ventas netas de $ 2.8 mil millones, utilidades netas de $ 157 millones y utilidades por acción de $ 2.46; las utilidades netas ajustadas fueron $ 192 millones, y la EPS ajustada fue $ 3.00.

Canaan Inc. Announces Adoption of Cryptocurrency Holding Policy and Strategic Long Position in Bitcoin

SINGAPORE, July 30, 2025 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today announced that it has adopted a...

FatPipe Reports First Quarter Fiscal Year 2026 Results

SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- FatPipe, Inc. (NASDAQ: FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class, application-aware, secure software-defined wide area...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers